These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1267559)

  • 41. Preclinical studies of recombinant factor IX.
    Schaub R; Garzone P; Bouchard P; Rup B; Keith J; Brinkhous K; Larsen G
    Semin Hematol; 1998 Apr; 35(2 Suppl 2):28-32. PubMed ID: 9565164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of a patient with factor IX deficiency (hemophilia B) with coronary bypass surgery.
    Scharfman WB; Rauch AE; Ferraris V; Burkart PT
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):765-6. PubMed ID: 8469013
    [No Abstract]   [Full Text] [Related]  

  • 43. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.
    Small M; Lowe GD; Douglas JT; Forbes CD; Prentice CR
    Thromb Haemost; 1982 Aug; 48(1):76-7. PubMed ID: 7135346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The treatment of inherited coagulation disorders].
    Blombäck M; Nilsson IM
    Lakartidningen; 1972 Dec; 69():Suppl 4:76-84. PubMed ID: 4540328
    [No Abstract]   [Full Text] [Related]  

  • 46. Relation of factor VIII and IX inhibitors with ABO blood groups in 150 patients with haemophilia A and B.
    Torghabeh HM; Pourfathollah A; Shooshtari MM; Yazdi ZR
    Iran J Allergy Asthma Immunol; 2006 Mar; 5(1):33-4. PubMed ID: 17242502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hemophilia B and aortocoronary bypass].
    Dimitrova A; Tsarianski G; Aleksandrov V; Kereshka P; Nachev G; Chirkov A
    Khirurgiia (Sofiia); 1995; 48(1):76-9. PubMed ID: 7474765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Behavior of the coagulation factor IX following intravenous application of Tralysol in persons with Hematophilia B].
    Bierstedt P
    Klin Wochenschr; 1970 May; 48(10):632-4. PubMed ID: 5314171
    [No Abstract]   [Full Text] [Related]  

  • 49. The international factor IX treatment network survey.
    Berntorp E; Shapiro AD; Waters J; Astermark J;
    Haemophilia; 2012 May; 18(3):e60-2. PubMed ID: 22404549
    [No Abstract]   [Full Text] [Related]  

  • 50. Diuretics and emergency management of hemophilioid disorders.
    Hoak JC; Christie DM
    N Engl J Med; 1971 Nov; 285(21):1204. PubMed ID: 5096649
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluating the potential benefits of the extravascular pool of factor IX.
    Lillicrap D
    Blood Coagul Fibrinolysis; 2021 Jan; 32(1):68-69. PubMed ID: 33170819
    [No Abstract]   [Full Text] [Related]  

  • 52. Human factor IX for the treatment of hemophilia B.
    Cardo LJ
    JAMA; 1991 Aug; 266(6):794. PubMed ID: 1865518
    [No Abstract]   [Full Text] [Related]  

  • 53. A simple assay for human factor IX: use of canine hemophilia B plasma as substrate.
    Goldsmith JC; Chung KS; Roberts HR
    Thromb Res; 1978 Mar; 12(3):497-502. PubMed ID: 653637
    [No Abstract]   [Full Text] [Related]  

  • 54. CCL18 as an alternative marker in Gaucher and Niemann-Pick disease with chitotriosidase deficiency.
    Chang KL; Hwu WL; Yeh HY; Lee NC; Chien YH
    Blood Cells Mol Dis; 2010 Jan; 44(1):38-40. PubMed ID: 19819171
    [No Abstract]   [Full Text] [Related]  

  • 55. [Coronary artery bypass with extracorporeal circulation in a patient with hemophilia B].
    Bukowski JG; De Brux JL; Ganascia B; Cottineau C; Jacob JP
    Ann Fr Anesth Reanim; 1996; 15(3):304-6. PubMed ID: 8758585
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquired factor IX deficiency. A report of two cases.
    Ozsoylu S; Ozer FL
    Acta Haematol; 1973; 50(5):305-14. PubMed ID: 4202635
    [No Abstract]   [Full Text] [Related]  

  • 57. [Not Available].
    Grätzel von Grätz P
    MMW Fortschr Med; 2024 Sep; 166(14):64. PubMed ID: 39210139
    [No Abstract]   [Full Text] [Related]  

  • 58. Factor IX deficiency and prolonged bleeding time.
    Gaston LW; Edson JR; Hartmann JR
    N Engl J Med; 1966 Aug; 275(5):252-5. PubMed ID: 5943270
    [No Abstract]   [Full Text] [Related]  

  • 59. [Contribution to the technic of factor IX activity determination. Antihemophilic globulin B; Christmas factor; PTC].
    Kurme A; Landbeck G
    Klin Wochenschr; 1967 Aug; 45(15):777-82. PubMed ID: 4873694
    [No Abstract]   [Full Text] [Related]  

  • 60. Circulating anticoagulant in patients with Gaucher's disease?
    Benjamin D; Joshua H; Douer D; Shaklai M; Krugliac Y; Pinkhas J
    Acta Haematol; 1979; 61(4):233-4. PubMed ID: 108906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.